| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2136be309d6c44157ddbe6d7ee2defc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2f1a621b67fabdb02f3c6f7a7eaea37 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2001-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_481927329d79ee084a3f0428868b04a0 |
| publicationDate |
2001-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0149690-A1 |
| titleOfInvention |
9-azabicyclo[4.2.1]non-2-ene derivatives as ligands for nicotinic acetylcholine receptors |
| abstract |
9-Azabicyclo[4.2.1]non-2-ene derivatives, which are ligands for nicotinic acetylcholine receptors (nAChRs), are disclosed. The compounds show a capacity to differentiate between different subtypes of nAChRs. Pharmaceutical compositions containing such compounds and a method of using such compounds in the treatment of a disease or disorder which is responsive to the activity of nAChR modulators are also disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6624167-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0212245-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0212245-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7022706-B2 |
| priorityDate |
2000-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |